What is the recommended dose of tetanus toxoid (TT) for a 5-month-old infant as part of the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Tetanus Toxoid for a 5-Month-Old Infant

The recommended dose of tetanus toxoid for a 5-month-old infant is 0.5 mL of DTaP vaccine administered intramuscularly into the anterolateral aspect of the thigh. 1

Standard Dosing

  • All DTaP vaccines are administered as a 0.5 mL dose intramuscularly, regardless of the child's weight or size. 1
  • Fractional doses (less than 0.5 mL) should never be administered, as they do not provide adequate protection. 1
  • The preferred injection site for infants and children through age 2 years is the anterolateral aspect of the thigh. 1

Routine Vaccination Schedule Context

At 5 months of age, this infant should be receiving their third dose of the DTaP primary series:

  • The standard DTaP schedule consists of doses at 2,4, and 6 months of age for the primary series. 1
  • A 5-month-old would typically be due for or have recently received the 4-month dose (second dose). 1
  • The third dose should not be administered before 14 weeks (approximately 3.5 months) of age. 1
  • If an accelerated schedule is needed, a minimum interval of 4 weeks should occur between doses. 1

Critical Clinical Considerations

Age-appropriate vaccine selection is essential:

  • DTaP (not Tdap, Td, or tetanus toxoid alone) must be used for children under 7 years of age. 1, 2, 3
  • DTaP provides necessary protection against diphtheria and pertussis in addition to tetanus. 2, 3
  • Using the wrong vaccine formulation for age is the most common error in tetanus vaccination. 2

Vaccine interchangeability:

  • Whenever feasible, the same manufacturer's DTaP product should be used for all doses in the series. 1
  • However, vaccination should not be deferred if the specific DTaP brand previously administered is unavailable or unknown. 1
  • Any licensed DTaP vaccine may be used to complete the vaccination series. 1

Administration Technique

  • DTaP may be administered simultaneously with other vaccines at different anatomical sites. 1
  • At 5 months of age, the infant may be receiving other vaccines such as IPV, Hib, pneumococcal conjugate, and hepatitis B vaccines concurrently. 1
  • Each vaccine should be given with a separate syringe at a different injection site. 1

Common Pitfall to Avoid

Never administer a reduced dose or split the 0.5 mL dose across multiple injections. The entire 0.5 mL must be given as a single intramuscular injection to ensure adequate immune response. 1 This is a fixed dose that does not vary based on the infant's size or weight.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetanus Prophylaxis Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Tdap Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.